Dr Dilip K Bobra, MD | |
2055 East Southern Avenue, Suite A, Tempe, AZ 85282-7507 | |
(480) 610-6602 | |
Not Available |
Full Name | Dr Dilip K Bobra |
---|---|
Gender | Male |
Speciality | Vascular Surgery |
Experience | 55 Years |
Location | 2055 East Southern Avenue, Tempe, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013099738 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0129X | Surgery - Vascular Surgery | 9436 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Banner Desert Medical Center | Mesa, AZ | Hospital |
Entity Name | Vascular Surgical Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265759484 PECOS PAC ID: 5698803146 Enrollment ID: O20100504000844 |
News Archive
Patients with heart failure who felt socially isolated were much more likely to die or be hospitalized than more socially connected patients, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
ExonHit Therapeutics yesterday presented clinical data on the validation set "Alzheimer patients versus healthy controls" for AclarusDx™ (formerly EHT Dx21), its blood-based diagnostic test for the detection of Alzheimer's disease (AD), at the 2nd Conference of Clinical Trials on Alzheimer's Disease (CTAD) in Las Vegas, USA.
A new study shows that non-severe infections that do not require hospitalisation can also increase the risk of subsequently developing schizophrenia or depression.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.
› Verified 9 days ago
Entity Name | East Valley Ambulatory Surgical Center Llc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1346944428 PECOS PAC ID: 3274990841 Enrollment ID: O20230613002559 |
News Archive
Patients with heart failure who felt socially isolated were much more likely to die or be hospitalized than more socially connected patients, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
ExonHit Therapeutics yesterday presented clinical data on the validation set "Alzheimer patients versus healthy controls" for AclarusDx™ (formerly EHT Dx21), its blood-based diagnostic test for the detection of Alzheimer's disease (AD), at the 2nd Conference of Clinical Trials on Alzheimer's Disease (CTAD) in Las Vegas, USA.
A new study shows that non-severe infections that do not require hospitalisation can also increase the risk of subsequently developing schizophrenia or depression.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Dilip K Bobra, MD 2072 East La Vieve Lane, Tempe, AZ 85284-3515 Ph: (480) 839-2682 | Dr Dilip K Bobra, MD 2055 East Southern Avenue, Suite A, Tempe, AZ 85282-7507 Ph: (480) 610-6602 |
News Archive
Patients with heart failure who felt socially isolated were much more likely to die or be hospitalized than more socially connected patients, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
ExonHit Therapeutics yesterday presented clinical data on the validation set "Alzheimer patients versus healthy controls" for AclarusDx™ (formerly EHT Dx21), its blood-based diagnostic test for the detection of Alzheimer's disease (AD), at the 2nd Conference of Clinical Trials on Alzheimer's Disease (CTAD) in Las Vegas, USA.
A new study shows that non-severe infections that do not require hospitalisation can also increase the risk of subsequently developing schizophrenia or depression.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.
› Verified 9 days ago
Jeffrey M Braxton, M.D., F.A.C.S. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6301 S Mcclintock Dr Ste 115, Tempe, AZ 85283 Phone: 480-775-8460 Fax: 480-775-8464 | |
Alan Lee Ansel, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2034 E Southern, 4, Tempe, AZ 85282 Phone: 602-252-2133 Fax: 602-258-0123 | |
Dr. Thomas Buddensick, M.D. Surgery Medicare: May Accept Medicare Assignments Practice Location: 1855 E Southern Ave, Tempe, AZ 85282 Phone: 480-712-6000 | |
Clayton C.k. Knight, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 S Rural Rd Ste 207, Tempe, AZ 85288 Phone: 520-428-5644 | |
Joshua Hamilton, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1920 E Baseline Rd, Tempe, AZ 85283 Phone: 800-233-3264 | |
Dr. Alan I Josephson, Surgery Medicare: Medicare Enrolled Practice Location: 1804 W Elliot Rd, Tempe, AZ 85284 Phone: 480-456-0444 Fax: 480-456-0449 |